(Total Views: 542)
Posted On: 07/31/2020 1:27:31 PM
Post# of 153907
Vicr,
Yes, noticed that NP was letting us know that several secondary points have been giving positive results.
And also the fact that he mentioned that these are important (they are).
Which brings the point that this will help showing the FDA that Leronlimab works.
Still we need to address the Clinical Improvement by reducing the total symptom score at day 14.
We will know in 10 days how do we stand in this one. However, is a very high bar for mild patients. I hope the moderate will help with the separation.
Yes, noticed that NP was letting us know that several secondary points have been giving positive results.
And also the fact that he mentioned that these are important (they are).
Which brings the point that this will help showing the FDA that Leronlimab works.
Still we need to address the Clinical Improvement by reducing the total symptom score at day 14.
We will know in 10 days how do we stand in this one. However, is a very high bar for mild patients. I hope the moderate will help with the separation.
(1)
(0)
